Strategies to prevent chronic neonatal lung disease

Journal of Paediatrics and Child Health

Volumn 32, Issue 6, 1996, Pages 477-479

  Schindler, M B ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

bronchopulmonary dysplasia; lung injury; ventilation strategies

Indexed keywords

CORTICOSTEROID; LUNG SURFACTANT; NITRIC OXIDE;

BAROTRAUMA; CHRONIC LUNG DISEASE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG DYSPLASIA; NEWBORN; OXYGEN TOXICITY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030477303     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1996.tb00957.x     Document Type: Short Survey

References (33)

1. Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr. Clin. North Am. 1994; 41: 277-315.
2. Philip AGS. Oxygen plus pressure plus time: The etiology of bronchopulmonary dysplasia. Pediatrics 1975; 55: 44-50.
3. Zimmerman JJ. Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin. Perinatol. 1995; 22: 429-56.
4. Jenkinson SG. Oxygen toxicity. New Horizons 1993; 1: 504-11.
5. Davis JM, Dickerson B, Metlay L, Penney DP. Differential effects of oxygen and barotrauma on lung injury in the neonatal piglet. Pediatr. Pulmonol. 1991; 10: 157-63.
6. West JB. (ed.) Best and Taylor's Physiological Basis of Medical Practice. Williams and Wilkins, Baltimore, 1985; 561-2.
7. Dreyfuss D, Soler P, Basset G, Saumon G. High Inflation pressure pulmonary edema: Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am. Rev. Respir. Dis. 1988; 137: 1159-64.
8. Gattinoni L, Pesenti A, Avalli L, Rossi F, Bombino M. Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic study. Am. Rev. Respir. Dis. 1987; 136: 730-6.
9. Moylan FMB, Walker AM, Kramer SS, Todres ID, Shannon DC. The relationship of bronchopulmonary dysplasia to the occurrence of alveolar rupture during positive pressure ventilation. Crit. Care Med. 1978; 3: 140-2.
10. Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: A prospective study. Crit. Care Med. 1994; 22: 1568-78.
11. Rosen WC, Mammel MC, Fisher JB et al. The effects of bedside pulmonary mechanics testing during infant mechanical ventilation. Pediatr. Pulmonol. 1993; 16: 147-52.
12. Wung JT, James LS, Kilchevsky E, James E. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics 1985; 76: 488-94.
13. 2, attenuates hypoxic-induced pulmonary vasoconstriction in newborn lambs. Pediatr. Res. 1986; 20: 113-17.
14. Morley CJ. Surfactant treatment for premature babies: a review of clinical trials. Arch. Dis. Childhood 1991; 66: 445-50.
15. Seeger W, Stohr G, Wolf HRD, Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J. Appl. Physiol. 1985; 58: 326-38.
16. Speer CP, Robertson B, Curstedt T et al. Randomized European mulitcenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single vs. multiple doses of curosurf. Pediatrics 1992; 89: 13-20.
17. Moses D, Holm BA, Spitale P, Liu MY, Enhorning G. Inhibition of pulmonary surfactant function by meconium. Am. J. Obstet. Gynecol. 1991; 164: 477-81.
18. Khammash H, Perlman M, Wojtulewicz J, Dunn M. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 1993; 92: 135-9.
19. Hudak ML, Farrell EE, Rosenberg AA et al. A multicenter randomized, masked comparison trial of natural vs. synthetic surfactant for the treatment of respiratory distress syndrome. J. Pediatr. 1996; 128: 396-406.
20. HiFO Study Group. Randomized study of high-frequency oscillatory ventilation in infants with severe respiratory distress syndrome. J. Pediatr. 1993; 122: 609-19.
21. Clark RH, Gerstmann DR, Null DM, deLemos RA. Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 1992; 89: 5-12.
22. Clark RH, Yoder BA, Sell MS. Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J. Pediatr. 1994; 124. 447-54.
23. Rodman DM, Yamaguchi T, Hasanuma K, O'Brien RF, McMurtry IF. Effects of hypoxia on endothelium-dependent relaxation in the rat pulmonary artery. Am. J. Physiol. 1990; 258: L207-14.
24. Geggel RL. Inhalational nitric oxide: a selective pulmonary vasodilator for treatment of persistent pulmonary hypertension of the newborn. J. Pediatr. 1993; 123: 76-9.
25. Kinsella JP, Neish SR, Dunbar D, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J. Pediatr. 1993; 123: 103-8.
26. UK collaborative ECMO trial group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996; 348: 75-84.
27. Hirschl RB, Pranikoff T, Gauger P, Schreiner RJ, Dechert R, Bartlett RH. Liquid ventilation in adults, children and full-term neonates. Lancet 1995; 346: 1201-2.
28. Van Marter U, Leviton A, Allred EN, Pagano M, Kuban KCK. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J. Pediatr. 1990; 116: 942-9.
29. Schindler MB, Bohn DB, Bryan AC. The effect of single-dose and continuous skeletal muscle paralysis on respiratory system compliance in paediatric intensive care patients. Intensive Care Med. 1996; 22: 486-91.
30. Bhutani VK, Abbasi S, Sivieri EM. Continuous skeletal muscle paralysis: Effect on neonatal pulmonary mechanics. Pediatrics 1988; 81: 419-22.
31. Schindler M, Cox P. A simple method of bronchoalveolar lavage. Anaesth. Intensive Care 1994; 22: 66-8.
32. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr. Res. 1994; 36: 122-8.
33. Yen TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind, controlled study. J. Pediatr. 1990; 117: 273-82.